1Packer R,J,Sutton LN,Elterman R,et al.Outcome for children with medulloblastoma treated with radiation and cisplatin,CCNU,and vincristine chemotherapy.Neurosurgery,1994,81:690-698.
2Deutsch M,Thomas PRM,Krischer J,et al.Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3600cGy/20) with reduced neuraxis irradiation (2340/13) in patients with low-stage medulloblastoma.Pediatr Neurosurg,1996,24:167-177.
3Fukunaga JN,Sandler HM,Marsh R,et al.The use of 3D conformal radiotherapy (3D CRT) to spare the cochlea in patients with medulloblastoma.Int J radiat Oncol Biol Phys,1998,41:77-82.
4Paulino AC,Narayana A,Mohideen MN,et al.Posterior fossa boost in medulloblastoma:An analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy.Int J Radiat Oncol Biol Phys,2000,46:281-286.
6Clair WHSt,Adams JA,Bues M,et al.Advantage of protons compated to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma.Int J Radiat Oncol Biol Phys,2004,58:727-734.
7Jakacki RI,Goldwein JW,Larsen RL,et al.Cardiac dysfunction following spinal irradiation during childhood.J Clin Oncol,1993,11:1033-1038.
8Shalet SM.Endocrine consequences of treatment of malignant disease.Arch Dis Child,1989,64:1635-1641.
9Bohne BA,Marks JE,Glasgow Gp.Delayed effects of ionizing radiation on the ear.Laryngoscope,1985,95:818-828.
10Grau C,Overgard J.Postirradiation sensorineural hearing loss:a common but ignored late radiation complication.Int J Radiat Oncol Bilol Phys,1996,36:515-517.
2Tommy K, Ingrid K, Per N, et al. Volumetric and dosimetric evaluation of radiation treatment planning: radiation comformity index. Int J Radiat Oncol Biol Phys, 1998,42:1169-176.
3Weber DC, Trofimov AV, Delaney MD, et al. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas, Int J Radiat Oncol Biol Phys, 2004,58: 1596-1606.
